Hemab Therapeutics to report third-quarter financial results

COAG•2026-11-03

Hemab Therapeutics will report third-quarter 2026 financial results on Nov. 10, covering the period ended Sept. 30, and hold a conference call at 8 a.m. ET to discuss the results and provide a corporate update.

1. Results and call

Hemab Therapeutics will report third-quarter 2026 financial results on Nov. 10, 2026, for the period ended Sept. 30. A conference call at 8 a.m. ET will discuss the results and provide a corporate update.

Hemab Therapeutics to report third-quarter financial results

1. Results and call

Related News

Lumentum Holdings Inc.: B. Riley cuts to neutral from buy, target to $770 from $1,142

JLL arranges $68.5 million sale of New Jersey industrial outdoor storage portfolio

ConnectM subsidiary Keen Labs names Karl Pomeroy president

LENSAR schedules third-quarter results release

Rocket One subsidiary Hoth ends HT-001 Phase 2a trial early after positive interim results